Harrow Health (HROW) revenue breakdown
By segment, Branded is the largest at 72% of fiscal 2025 revenue, growing 97% a year over 2 years.
By product, Product Sales Net is the largest at 100% of fiscal 2025 revenue, growing 34% a year over 8 years.
Revenue by segment
Fiscal years, as Harrow Health reports them in its 10-K filings; fiscal 2025 total $272M.
| Segments | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|
| Branded | $50M | $116M | $196M | 72% |
| ImprimisRx | $80M | $83M | $77M | 28% |
Revenue by product
Fiscal years, as Harrow Health reports them in its 10-K filings; fiscal 2025 total $272M.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Product Sales Net | $27M | $41M | $51M | $48M | $69M | $84M | $117M | $199M | $272M | 100% |
| Other Revenues | — | — | — | — | $99,000 | $1M | $13M | $995,000 | $394,000 | 0% |
| Commissions | — | — | — | $356,000 | $3M | $4M | — | — | — | — |
| License | $90,000 | $38,000 | $28,000 | $36,000 | $20,000 | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for HROW.
Open HROW in InvestinglyQuestions
Where does Harrow Health make its money?
In fiscal 2025, by segment: Branded $196M, ImprimisRx $77M.
From Harrow Health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.